Revised Central Nervous System Neuropenetration-Effectiveness Score is Associated with Cognitive Disorders in HIV-Infected Patients with Controlled Plasma Viraemia
- 1 February 2013
- journal article
- research article
- Published by SAGE Publications in Antiviral Therapy
- Vol. 18 (2) , 153-160
Abstract
Background: The objective of our study was to compare two different central nervous system penetration- effectiveness (CPE) scores for the prediction of cognitive dysfunction in HIV-infected patients. Methods: We performed a cross-sectional single cohort study, consecutively enrolled during routine outpatient visits. HIV-infected subjects on antiretroviral therapy with plasma HIV RNA+ T-cell count, orCPE rank did not show an association with cognitive performance ( P=0.704). By contrast, patients with revCPE rank ≥6 (OR 0.32, 95% CI 0.11, 0.95; P=0.039) and adherence ≥80% (OR 0.39, 95% CI 0.15, 0.99; P=0.047) showed a decreased risk of cognitive impairment. Conclusions: A high prevalence of ANI was observed in virologically suppressed HIV-infected individuals. The revCPE rank showed improved association with neurocognitive dysfunction over the orCPE rank. Moreover, a relationship between cognitive impairment and adherence to antiretroviral therapy was found.Keywords
This publication has 31 references indexed in Scilit:
- Cardiovascular risk factors and carotid intima‐media thickness are associated with lower cognitive performance in HIV‐infected patientsHIV Medicine, 2012
- Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?HIV Medicine, 2011
- Antiretroviral therapy CNS penetration and HIV-1–associated CNS diseaseNeurology, 2011
- HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral TreatmentThe Journal of Infectious Diseases, 2010
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapyNeurology, 2010
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performanceAIDS, 2009
- Cognitive Neuropsychology of HIV-Associated Neurocognitive DisordersNeuropsychology Review, 2009
- Aging, Neurocognition, and Medication Adherence in HIV InfectionThe American Journal of Geriatric Psychiatry, 2009
- Darunavir Concentrations in Cerebrospinal Fluid and Blood in HIV-1–Infected IndividualsAIDS Research and Human Retroviruses, 2009
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008